Edwards Lifesciences
EW
₹7,007
Share price
2.52%
Change (1 day)
31.28%
Change (1 year)
Categories
Revenue for Edwards Lifesciences (EW)
Revenue in 2025 (TTM): ₹468.69 Billion
According to Edwards Lifesciences's latest financial reports the company's current revenue (TTM 
) is ₹482.31 Billion. In 2024 the company made a revenue of ₹468.05 Billion an increase over the revenue in the year 2023 that were of ₹460.58 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Edwards Lifesciences from 2000 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | ₹468.69 B | 0.14% |
| 2024 | ₹468.05 B | 1.62% |
| 2023 | ₹460.58 B | 3.41% |
| 2022 | ₹445.39 B | 14.36% |
| 2021 | ₹389.46 B | 21.41% |
| 2020 | ₹320.78 B | 3.46% |
| 2019 | ₹310.06 B | 19.11% |
| 2018 | ₹260.30 B | 18.67% |
| 2017 | ₹219.34 B | 8.91% |
| 2016 | ₹201.39 B | 21.53% |
| 2015 | ₹165.71 B | 12.56% |
| 2014 | ₹147.22 B | 16.5% |
| 2013 | ₹126.37 B | 21.5% |
| 2012 | ₹104.00 B | 17.13% |
| 2011 | ₹88.79 B | 36.95% |
| 2010 | ₹64.84 B | 5.75% |
| 2009 | ₹61.31 B | 3.06% |
| 2008 | ₹59.49 B | 38.93% |
| 2007 | ₹42.82 B | -6.8% |
| 2006 | ₹45.94 B | 2.31% |
| 2005 | ₹44.90 B | 11.31% |
| 2004 | ₹40.34 B | 2.97% |
| 2003 | ₹39.17 B | 16.05% |
| 2002 | ₹33.75 B | 1.11% |
| 2001 | ₹33.39 B | -14.15% |
| 2000 | ₹38.89 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | ₹1.528 T | 216.91% | 🇺🇸 USA |
 Merit Medical MMSI | ₹120.89 B | -74.93% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | ₹19.70 B | -95.92% | 🇺🇸 USA |
 CryoLife CRY | ₹26.02 B | -94.60% | 🇺🇸 USA |
 Medtronic MDT | ₹2.920 T | 505.49% | 🇮🇪 Ireland |
 ICU Medical
ICUI | ₹210.74 B | -56.31% | 🇺🇸 USA |